5 studies found for:    15470215 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy
Condition: Hepatitis B Virus-Related Hepatocellular Carcinoma
Intervention:
2 Recruiting Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
Condition: Hepatocellular Carcinoma
Intervention: Drug: Lamivudine 100mg once daily; or Entecavir 0.5mg once daily.
3 Unknown  Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
Condition: Hepatitis B
Intervention: Drug: Entecavir
4 Completed
Has Results
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy;   Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine
5 Enrolling by invitation Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis
Conditions: Hepatitis B Virus;   Decompensated Cirrhosis
Intervention: Drug: Entecavir

Indicates status has not been verified in more than two years